Virus-like particle containing capsid proteins connected by linker
US-2025197454-A1 · Jun 19, 2025 · US
This page is not indexed by search engines while we improve data quality.
Picornaviridae, e.g. coxsackie virus, echovirus, enterovirus
Picornaviridae, e.g. coxsackie virus, echovirus, enterovirus · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K14/085 |
| Official title | Picornaviridae, e.g. coxsackie virus, echovirus, enterovirus |
| Display label | Picornaviridae, e.g. coxsackie virus, echovirus, enterovirus |
| Total patents | 22 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is rapidly declining.
| Year | Patents |
|---|---|
| 2015 | 3 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 5 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Rna replicon for improving gene expression and use thereof
US-2024417751-A1 · Dec 19, 2024 · US
Modified norovirus VP1 proteins and VLPs comprising modified norovirus VP1 proteins
US-11759512-B2 · Sep 19, 2023 · US
Compositions and methods for detecting picobirnavirus
US-2023227924-A1 · Jul 20, 2023 · US
Composite polypeptide monomer, aggregate of said composite polypeptide monomer having cell penetration function, and norovirus component vaccine for subcutaneous, intradermal, percutaneous, or intramuscular administration and having said aggregate as effective component thereof
US-11517616-B2 · Dec 6, 2022 · US
Senecavirus a immunogenic compositions and methods thereof
US-2022313812-A1 · Oct 6, 2022 · US
Senecavirus a immunogenic compositions and methods thereof
US-11179457-B2 · Nov 23, 2021 · US
Composite polypeptide monomer, aggregate of said composite polypeptide monomer having cell penetration function, and norovirus component vaccine for subcutaneous, intradermal, percutaneous, or intramuscular administration and having said aggregate as effective component thereof
US-2021299240-A1 · Sep 30, 2021 · US
Modified norovirus vp1 proteins and vlps comprising modified norovirus vp1 proteins
US-2021128714-A1 · May 6, 2021 · US
Senecavirus a immunogenic compositions and methods thereof
US-2020306362-A1 · Oct 1, 2020 · US
Picornavirus-like particle production in plants
US-10590173-B2 · Mar 17, 2020 · US
T cell receptors that bind to ny-eso-1 and methods of use thereof
US-2020040358-A1 · Feb 6, 2020 · US
Immunogenic rhinovirus peptides
US-10493145-B2 · Dec 3, 2019 · US
Foot and mouth disease virus serotype o (fmdv-o) vaccine
US-2019275138-A1 · Sep 12, 2019 · US
Picornavirus-like particle production in plants
US-2019112341-A1 · Apr 18, 2019 · US
Immunogenic rhinovirus peptides
US-2019076519-A1 · Mar 14, 2019 · US
Picornavirus-like particle production in plants
US-10202423-B2 · Feb 12, 2019 · US
Vaccine
US-10058603-B2 · Aug 28, 2018 · US
Vaccine
US-2016022803-A1 · Jan 28, 2016 · US
Targeted heterologous antigen presentation on calicivirus virus-like particles
US-2015252082-A1 · Sep 10, 2015 · US